eagle-i Harvard UniversityHarvard University
See it in Search

Circulating Tumor Cell Core (BWH)

Director: Lowe, Alarice MD

Location: Brigham and Women's Hospital, Medical Research Building, 3rd Floor, 75 Francis St., Boston, MA 02115


The Circulating Tumor Cell Core Facility uses immunomagnetic technology developed by Veridex, LLC (Raritan, NJ) to isolate rare tumor cells from whole blood. Isolated tumor cells can then be counted or used for downstream analysis such as molecular studies or flow cytometry.





  • CellTracks Analyzer II ( Cell assay platform )

    Fluorescence based cellular analysis of cells captured by the CellTracks AutoPrep system. Use for the quantitative analysis of circulating tumor cells.

  • CellTracks AutoPrep System ( Cell assay platform )

    Automated preparation system for the standardized preparation of blood samples to detect circulating tumor cells using magnetic cell capture and immunostaining.


  • Circulating Tumor Cell analysis ( Material analysis service )

    Analysis of blood samples (7.5mls collected in Veridex CellSave tubes) for the presence of circulating tumor cells

  • Circulating Tumor Cell Purification ( Material processing service )

    Processed samples of circulating tumor cells are returned to investigators for downstream analysis (i.e. profiling).

Last updated: 2013-02-21T10:26:49.892-06:00

Copyright © 2016 by the President and Fellows of Harvard College
The eagle-i Consortium is supported by NIH Grant #5U24RR029825-02 / Copyright 2016